Stratus® CS cardiac troponin I method: performance characteristics including imprecision at low concentrations
Authors:
- Robert H ChristensonRCRobert H Christenson
- Denise R CervelliDCDenise R Cervelli
- Roger S BauerRBRoger S Bauer
- Marilynn GordonMGMarilynn Gordon
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (8) , 679-683
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of Imprecision for Cardiac Troponin Assays at Low-Range ConcentrationsClinical Chemistry, 2004
- Performance of a Revised Cardiac Troponin Method That Minimizes Interferences from Heterophilic AntibodiesClinical Chemistry, 2002
- Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial InfarctionResults From a Randomized TrialJAMA, 2001
- Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference MaterialsClinical Chemistry, 2001
- Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionJACC, 2001
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Rapid Measurement of Cardiac Markers on Stratus CSClinical Chemistry, 2000
- Clinical Efficacy of Three Assays for Cardiac Troponin I for Risk Stratification in Acute Coronary Syndromes: A Thrombolysis In Myocardial Infarction (TIMI) 11B SubstudyClinical Chemistry, 2000
- Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest PainClinical Chemistry, 1999